Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Michelle Tarver
Person

Michelle Tarver

Tracked across 2 events · 14 articles · First seen Jun 13, 2026 · Last active Aug 20, 2026

Sentiment
55
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
6 60
Regulatory
FDA Clears Dexcom Stelo for Children
Impact: Michelle Tarver, director of the United States — Food and Drug Administration's Center for Devices and Radiological Health, commented on the importance of the clearance for pediatric patients.
Jun 13, 2026 · 7 articles
4 50
Regulatory
FDA Authorizes Aletta Robotic Blood Draw Device
The U.S. United States — Food and Drug Administration (FDA) has granted marketing authorization to Vitestro for the Aletta, the first standalone robotic device capable of drawing blood from a patient's arm without hands-on operator…
Impact: Michelle Tarver, Director of the FDA's Center for Devices and Radiological Health, publicly endorsed the authorization, highlighting its role in addressing the phlebotomist shortage. Her statement underscores the FDA's support for the device, though her personal impact is limited to her official role.
Aug 19, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Michelle Tarver live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.